statistiche ricercatore

Continente	#
NA - Nord America	1.308
EU - Europa	521
AS - Asia	508
SA - Sud America	121
AF - Africa	8
OC - Oceania	7
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.474

Nazione	#
US - Stati Uniti d'America	1.290
SG - Singapore	167
GB - Regno Unito	142
CN - Cina	128
DE - Germania	118
BR - Brasile	92
HK - Hong Kong	64
FI - Finlandia	63
VN - Vietnam	55
SE - Svezia	51
IT - Italia	35
FR - Francia	23
RU - Federazione Russa	23
UA - Ucraina	22
TR - Turchia	18
NL - Olanda	15
IN - India	12
AR - Argentina	11
BD - Bangladesh	11
BG - Bulgaria	9
CA - Canada	9
AU - Australia	7
KR - Corea	7
AE - Emirati Arabi Uniti	6
ID - Indonesia	6
IQ - Iraq	6
MX - Messico	6
CO - Colombia	5
PK - Pakistan	5
BE - Belgio	4
EC - Ecuador	4
ES - Italia	4
PH - Filippine	4
SA - Arabia Saudita	4
IE - Irlanda	3
JP - Giappone	3
VE - Venezuela	3
ZA - Sudafrica	3
CH - Svizzera	2
CL - Cile	2
MA - Marocco	2
NP - Nepal	2
PY - Paraguay	2
AT - Austria	1
EG - Egitto	1
EU - Europa	1
HU - Ungheria	1
IL - Israele	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
KH - Cambogia	1
KZ - Kazakistan	1
MK - Macedonia	1
MU - Mauritius	1
MY - Malesia	1
PE - Perù	1
PL - Polonia	1
PR - Porto Rico	1
QA - Qatar	1
RO - Romania	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TH - Thailandia	1
TW - Taiwan	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	2.474

Nome	#
Structural models and binding site prediction of the C-terminal domain of human Hsp90: a new target for anticancer drugs	427
Analytical and Simulation-Based Models for Drug Release and Gel-Degradation in a Tetra-PEG Hydrogel Drug-Delivery System	371
A computational workflow for the design of irreversible inhibitors of protein kinases	331
Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening	292
Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors	283
Exploring the binding site of C-terminal Hsp90 inhibitors	271
In vitro effects of Plasmodium falciparum dihydrofolate reductase inhibitors on normal and cancer cell proliferation	269
Relationship between quantum-chemical descriptors of proton dissociation and experimental acidity contants of variously hydroxylated coumarins. Identification of the biologically active species for xanthine oxidase inhibition	246
Totale	2.490

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	14	0	0	0	0	0	0	0	0	0	0	0	14
2021/2022	181	11	27	21	7	1	5	14	6	18	21	37	13
2022/2023	158	19	23	6	18	14	26	3	15	20	3	8	3
2023/2024	93	2	4	2	3	19	10	5	30	0	1	8	9
2024/2025	473	8	7	8	21	70	69	61	68	50	21	37	53
2025/2026	793	54	37	53	84	123	62	85	38	81	109	34	33
Totale													2.490